COMP <GO>
DCTH vs MRK // 10Y YIELD & FRED MACRO BETA
Delcath Systems Inc. (NASDAQ) VS. Merck & Company Inc. (NYSE) • 15-METRIC TALLY: DCTH 5
— MRK 6
■ METRIC PARITY
LAST: $14.04 (-4.10%) • MKT CAP: $508.0M
macro-sensitivity
—
LAST: $149.52 (+2.18%) • MKT CAP: $361.02B
macro-sensitivity
0.92
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (DCTH VS. MRK)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | DCTH | MRK | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 86.20% | 74.80% | +11.40 | DCTH | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 0.80% | 20.70% | -19.90 | MRK | /roic <GO> |
| EV/EBITDA & P/E Valuation | — | 15.3x | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | 4.13% | 3.42% | +0.71 | DCTH | /fcf-yield <GO> |
| Operating Margin | 0.80% | 34.30% | -33.50 | MRK | /operating-margins <GO> |
| Net Profit Margin | 3.20% | 28.10% | -24.90 | MRK | /net-margins <GO> |
| Revenue Growth (YoY) | 129.10% | 1.30% | +127.80 | DCTH | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 2.26% | -2.26 | MRK | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 20.33 | 5.19 | +15.14 | DCTH | /balance-sheet <GO> |
| Piotroski F-Score Quality | 8/9 | 7/9 | +1.00 | DCTH | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 46.0 | 51.7 | -5.70 | MRK | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta ACTIVE | — | 0.92 | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | — | 18.4x | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $508.0M | $361.02B | -$360.51B | MRK | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | DCTH REV | MRK REV | DCTH GROSS % | MRK GROSS % | DCTH FCF | MRK FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $85.2M | $65.01B | 86.2% | 74.8% | $21.0M | $12.36B |
| FY 2024 | $37.2M | $64.17B | 83.4% | 76.3% | -$19.2M | $18.10B |
| FY 2023 | $2.1M | $60.12B | — | — | -$31.3M | $10.30B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
DCTH // BETA —
MRK // BETA 0.92